{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:33:15Z","timestamp":1784158395239,"version":"3.55.0"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We evaluated the pharmacokinetic profile of ciprofloxacin and its penetration into bronchial secretions of critically ill patients with chronic obstructive pulmonary disease (COPD). Twenty-five mechanically ventilated patients with severe COPD who were suffering from an acute, infectious exacerbation were included in this prospective, open-label study. All subjects received a 1-hour intravenous infusion of 400 mg ciprofloxacin every 8 h. Serial blood and bronchial secretion samples were obtained at steady state, and concentrations were determined using high-performance liquid chromatography. The pharmacodynamic parameters that are associated with the efficacy of fluoroquinolones against Gram-negative pathogens were also calculated. The mean peak (maximum) concentration (<jats:italic>C<\/jats:italic><jats:sub>max<\/jats:sub>) and trough (minimum) concentration in plasma were 5.37 \u00b1 1.57 and 1 \u00b1 0.53 mg\/liter, respectively. Mean values for volume of distribution, clearance, half-life, and area under the curve from 0 to 24 h (AUC<jats:sub>0\u201324<\/jats:sub>) were 169.87 \u00b1 84.11 liters, 26.96 \u00b1 8.86 liters\/h, 5.35 \u00b1 2.21 h, and 47.41 \u00b1 17.02 mg \u00b7 h\/liter, respectively. In bronchial secretions, a mean<jats:italic>C<\/jats:italic><jats:sub>max<\/jats:sub>of 3.08 \u00b1 1.21 mg\/liter was achieved in 3.12 \u00b1 1.01 h, and the penetration ratio was 1.16 \u00b1 0.59. The target of AUC<jats:sub>0\u201324<\/jats:sub>\/MIC of \u2265125 was attained in all patients, in the majority of them (76%), and in none at MICs of 0.125, 0.25, and 1 \u03bcg\/ml, respectively. Slightly better results were obtained for the ratio<jats:italic>C<\/jats:italic><jats:sub>max<\/jats:sub>\/MIC of \u226510. In conclusion, ciprofloxacin demonstrates excellent penetration into bronchial secretions. There is wide interindividual variability in its pharmacokinetic parameters in critically ill COPD patients and inadequate pharmacodynamic exposure against bacteria with MICs of \u22650.5 \u03bcg\/ml.<\/jats:p>","DOI":"10.1128\/aac.00566-10","type":"journal-article","created":{"date-parts":[[2011,6,14]],"date-time":"2011-06-14T17:44:05Z","timestamp":1308073445000},"page":"4149-4153","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["Pharmacokinetics of Ciprofloxacin and Its Penetration into Bronchial Secretions of Mechanically Ventilated Patients with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1128","volume":"55","author":[{"given":"Paschalina","family":"Kontou","sequence":"first","affiliation":[{"name":"A'Intensive Care Unit, G. Papanikolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Chatzika","sequence":"additional","affiliation":[{"name":"Respiratory Infections Unit, G. Papanikolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Pitsiou","sequence":"additional","affiliation":[{"name":"Respiratory Failure Unit, Aristotle University, G. Papanikolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Stanopoulos","sequence":"additional","affiliation":[{"name":"Respiratory Failure Unit, Aristotle University, G. Papanikolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Argyropoulou-Pataka","sequence":"additional","affiliation":[{"name":"Respiratory Failure Unit, Aristotle University, G. Papanikolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kioumis","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Aristotle University, G. Papanikolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.6.1171"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1155\/2003\/486285"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00105.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/22.4.499"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(20)31133-5"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm228"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00014304"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.3.331"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.3.483"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.6.1542"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.5.1073"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.5.1153"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.4.1114"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00124605"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(03)00151-1"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.7.2464-2470.2004"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.3.672"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.5.993"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.9.2235"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01284-07"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3468-3473.2001"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl226"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.2.125"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200703-456SO"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181961bff"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.4.901"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.03.015"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10051130"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.4.1003"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.5.9711044"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.3.521"},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1183\/09031936.93.03060715","article-title":"Pharmacokinetics of antibiotics in the lungs","volume":"3","author":"Valcke Y.","year":"1990","unstructured":"ValckeY. PauwelsR. Van der StraetenM.. 1990. Pharmacokinetics of antibiotics in the lungs. Eur. Respir. J. 3:715\u2013722.","journal-title":"Eur. Respir. J"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2007.11.011"},{"key":"e_1_3_1_36_2","unstructured":"WHO. 2008. WHO Geneva Switzerland. Who.int\/mediacentre\/factsheets\/fs310\/en\/index.html."},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00055705"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.10.4009-4014.2005"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00566-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00566-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T10:47:43Z","timestamp":1686134863000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00566-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1128\/AAC.00566-10"],"URL":"https:\/\/doi.org\/10.1128\/aac.00566-10","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"2010-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-06-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-08-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}